**Abstract**

Previously, we have demonstrated that the activation of the GPR40/free fatty acid receptor 1 (GPR40/FFAR1) signaling may play an important role in the regulation of the descending pain control system. Here, we examined the involvement of hypothalamic GPR40/FFAR1 signaling in the development of chronic pain. We used GPR40/FFAR1 knock out (GPR40KO) mice or wild type (WT) mice. A plantar incision was performed in mice. The complete Freund's adjuvant (CFA) was intraplantary injected in mice. Mechanical allodynia and thermal hyperalgesia were evaluated using von Frey filaments and plantar test, respectively. The repeated administration of GW1100, a GPR40/FFAR1 antagonist, CFA or incision-induced mechanical allodynia compared to vehicle treated mice. The repeated GW1100 treated mice significantly increased phosphorylated ERK (p-ERK) in the spinal cord after low threshold touch stimulation. The level of the hypothalamic docosahexaenoic acid (DHA), a GPR40/FFAR1 agonist, significantly increased at 2 days after surgery compared to sham group. Furthermore, GPR40KO mice were exacerbated incision-induced mechanical allodynia, but not thermal hyperalgesia compared to WT mice. Our findings suggest that the dysfunction of this signaling pathway may be associated with the development of chronic pain.
